Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

21. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy.

Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. BACKGROUND: Incidence of gestational diabetes mellitus (GDM) is increasing worldwide. Blood glucose monitoring plays a crucial part in maintaining glycaemic control in women with GDM and is generally recommended by healthcare professionals. There are several different methods for monitoring blood glucose which can be carried out in different settings (e.g. at home versus in hospital). OBJECTIVES (...) -for-gestational age; perinatal mortality; death or serious morbidity composite; childhood/adulthood neurosensory disability;- secondary outcomes for mothers: that is, induction of labour; perineal trauma; postnatal depression; postnatal weight retention or return to pre-pregnancy weight; and- secondary outcomes for children: that is, neonatal hypoglycaemia; childhood/adulthood adiposity; childhood/adulthood type 2 diabetes. MAIN RESULTS: We included 11 RCTs (10 RCTs; one qRCT) that randomised 1272 women

Cochrane2017

22. microRNA-503 contribute to pancreatic beta cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus

microRNA-503 contribute to pancreatic beta cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus 29285014 2018 11 13 1611-2156 16 2017 EXCLI journal EXCLI J microRNA-503 contribute to pancreatic beta cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus. 1177-1187 10.17179/excli2017-738 Loss of pancreatic β cells is involved in pathogenesis of gestational diabetes mellitus (GDM). Recently, several studies have elucidated the connection between (...) ):e0116067 25658748 CMAJ. 1992 Jun 1;146(11):2021-9 1596851 PLoS One. 2011;6(8):e23925 21887347 Lab Invest. 2015 Dec;95(12):1387-97 26367486 Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9250-5 18587048 J Clin Invest. 2001 Dec;108(11):1631-8 11733558 Hypertens Pregnancy. 2003;22(2):109-27 12908996 Int J Chron Obstruct Pulmon Dis. 2017 Feb 14;12 :627-638 28243080 J Clin Endocrinol Metab. 2016 Jul;101(7):2683-91 27023450 gestational diabetes mellitus mTOR microRNA-503 pancreatic beta-cells 2017 08 20 2017

EXCLI journal2017 Full Text: Link to full Text with Trip Pro

23. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.

Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. BACKGROUND: While most guidance recommends the use of insulin in women whose pregnancies are affected by pre-existing diabetes, oral anti-diabetic agents may be more acceptable to women. The effects of these oral anti-diabetic agents on maternal and infant health outcomes need to be established in pregnant (...) women with pre-existing diabetes or impaired glucose tolerance, as well as in women with previous gestational diabetes mellitus preconceptionally or during a subsequent pregnancy. OBJECTIVES: To investigate the effects of oral anti-diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre-existing diabetes, on maternal and infant health. The use of oral anti-diabetic agents

Cochrane2017

24. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes.

Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. BACKGROUND: Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for mothers and their infants both perinatally and long term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention in the interconception period to improve maternal and infant health outcomes. OBJECTIVES: To assess the effects

Cochrane2017

25. Gestational Diabetes Mellitus and Frequency of Blood Glucose Monitoring: A Randomized Controlled Trial

Gestational Diabetes Mellitus and Frequency of Blood Glucose Monitoring: A Randomized Controlled Trial 28594772 2017 06 08 2017 07 31 2017 07 31 1873-233X 130 1 2017 Jul Obstetrics and gynecology Obstet Gynecol Gestational Diabetes Mellitus and Frequency of Blood Glucose Monitoring: A Randomized Controlled Trial. 163-170 10.1097/AOG.0000000000002101 To assess whether testing blood glucose four times daily compared with four times every other day would lead to similar birth weights among (...) patients with gestational diabetes mellitus (GDM). This noninferiority randomized controlled trial was conducted at five centers. After receiving a diagnosis of GDM, women tested their blood glucose every day for 7 days. After that period, compliant women without hyperglycemia requiring treatment were randomized to either blood glucose testing four times a day or every other day. Noninferiority would be declared if the mean birth weight in the every-other-day group was no higher than 165 g (5

EvidenceUpdates2017

26. Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus

Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus UTCAT3223, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus Clinical Question In pregnant women, does having periodontal disease increase the risk of gestational diabetes mellitus (GDM)? Clinical Bottom Line Studies have shown that periodontal (...) disease and its inflammatory mediators are associated with an increased risk for the development of gestational diabetes. This is based on a meta-analysis of 5,724 pregnant patients including 624 cases of GDM. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Abariga/2016 Females with periodontal disease Meta-Analysis Key results Forty-four articles were reviewed, and 10 studies met the eligibility criteria

UTHSCSA Dental School CAT Library2017

27. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial

The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial 28325784 2017 03 22 2017 03 22 1935-5548 2017 Mar 21 Diabetes care Diabetes Care The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. dc162449 10.2337/dc16-2449 This study investigated if inositol in a combination of myo-inositol and D-Chiro-inositol would prevent gestational diabetes mellitus (GDM (...) ) in women with a family history of diabetes. This was a randomized controlled trial that examined whether inositol from the first antenatal visit prevents GDM. The trial was carried out in a single-center tertiary referral center. Women with a family history of diabetes were enrolled at the first antenatal visit. They were randomized to the intervention group, who received a combination of 1,100 mg myo-inositol, 27.6 g D-Chiro inositol, and 400 mcg folic acid, or to the control group, who received 400

EvidenceUpdates2017

29. Perceived needs in women with gestational diabetes: A qualitative study

Perceived needs in women with gestational diabetes: A qualitative study 28163857 2018 11 13 2008-5842 8 12 2016 Dec Electronic physician Electron Physician Perceived needs in women with gestational diabetes: A qualitative study. 3412-3420 10.19082/3412 Diabetes is the most common medical complication of pregnancy. It can be associated with many complications for mother and fetus. Gestational diabetes is also one of the main health issues in Iran. Therefore, the present study is aimed (...) at a deeper understanding of women's experiences of gestational diabetes and their perceived needs to inform future lifestyle interventions. This qualitative content analysis study was carried out in 2015. Participants were pregnant women diagnosed with gestational diabetes in the 24 th to 36 th week of pregnancy, who were referred to the clinics affiliated with Shahid Beheshti Medical Science University in Tehran, Iran. In-depth interviews were conducted with participants, using semi-structured questions

Electronic physician2016 Full Text: Link to full Text with Trip Pro

30. Exercise and its role in gestational diabetes mellitus

Exercise and its role in gestational diabetes mellitus 29063044 2018 11 13 2095-882X 2 4 2016 Dec Chronic diseases and translational medicine Chronic Dis Transl Med Exercise and its role in gestational diabetes mellitus. 208-214 10.1016/j.cdtm.2016.11.006 Gestational diabetes mellitus (GDM) refers to diabetes diagnosed in the second or third trimester of pregnancy that is not clearly either type 1 or type 2 diabetes. GDM is a common medical complication in pregnancy that has been rapidly (...) Physiology and Biochemistry, The University of Western Australia, Perth, Western Australia 6009, Australia. Yang Hui-Xia HX Department of Obstetrics and Gynecology of Peking University First Hospital, Beijing 100034, China. eng Journal Article Review 2016 12 20 China Chronic Dis Transl Med 101679934 2095-882X Exercise Gestational diabetes mellitus Insulin resistance Pregnancy 2016 01 15 2017 10 25 6 0 2017 10 25 6 0 2017 10 25 6 1 epublish 29063044 10.1016/j.cdtm.2016.11.006 S2095-882X(16)30119-0

Chronic diseases and translational medicine2016 Full Text: Link to full Text with Trip Pro

31. Diagnosis, prevention and management of gestational diabetes mellitus

Diagnosis, prevention and management of gestational diabetes mellitus 29063042 2018 11 13 2095-882X 2 4 2016 Dec Chronic diseases and translational medicine Chronic Dis Transl Med Diagnosis, prevention and management of gestational diabetes mellitus. 199-203 10.1016/j.cdtm.2016.11.004 Wang Chen C Department of Obstetrics and Gynecology of Peking University First Hospital, Beijing 100034, China. Yang Hui-Xia HX Department of Obstetrics and Gynecology of Peking University First Hospital, Beijing (...) Diabetes Res Clin Pract. 2014 Mar;103(3):341-63 24847517 Int J Gynaecol Obstet. 2015 Oct;131 Suppl 4:S213-53 26433230 Obstet Gynecol. 2013 Aug;122(2 Pt 1):406-16 23969827 Diagnosis Gestational diabetes mellitus Management Postpartum follow-up Prevention 2016 08 10 2017 10 25 6 0 2017 10 25 6 0 2017 10 25 6 1 epublish 29063042 10.1016/j.cdtm.2016.11.004 S2095-882X(16)30062-7 PMC5643832

Chronic diseases and translational medicine2016 Full Text: Link to full Text with Trip Pro

32. Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial

Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial 27813240 2016 11 04 2017 02 22 1471-0528 124 4 2017 Mar BJOG : an international journal of obstetrics and gynaecology BJOG Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial. 669-677 10.1111/1471-0528.14389 To evaluate maternal and perinatal outcomes after induction of labour versus expectant management in pregnant (...) women with gestational diabetes at term. Multicentre open-label randomised controlled trial. Eight teaching hospitals in Italy, Slovenia, and Israel. Singleton pregnancy, diagnosed with gestational diabetes by the International Association of Diabetes and Pregnancy Study Groups criteria (IADPSGC), between 38(+0) and 39(+0) weeks of gestation, without other maternal or fetal conditions. Patients were randomly assigned to induction of labour or expectant management and intensive follow-up. Data were

EvidenceUpdates2016

33. Regular Exercise to Prevent the Recurrence of Gestational Diabetes Mellitus: A Randomized Controlled Trial

Regular Exercise to Prevent the Recurrence of Gestational Diabetes Mellitus: A Randomized Controlled Trial 27607876 2016 09 24 2017 02 03 1873-233X 128 4 2016 Oct Obstetrics and gynecology Obstet Gynecol Regular Exercise to Prevent the Recurrence of Gestational Diabetes Mellitus: A Randomized Controlled Trial. 819-27 10.1097/AOG.0000000000001632 To investigate the effect of a supervised home-based exercise program on the recurrence and severity of gestational diabetes mellitus (GDM) together (...) with other aspects of maternal health and obstetric and neonatal outcomes. This randomized controlled trial allocated women with a history of GDM to an exercise intervention (14-week supervised home-based stationary cycling program) or to a control group (standard care) at 13±1 weeks of gestation. The primary outcome was a diagnosis of GDM. Secondary outcomes included maternal fitness, psychological well-being, and obstetric and neonatal outcomes. A sample size of 180 (90 in each group) was required

EvidenceUpdates2016

34. Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review

Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review 27637772 2016 09 30 2017 03 15 2017 03 15 1836-9561 62 4 2016 Oct Journal of physiotherapy J Physiother Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review. 188-96 10.1016/j.jphys.2016.08.003 S1836-9553(16)30053-4 Does exercise improve postprandial glycaemic control in women diagnosed with gestational diabetes mellitus (...) ? A systematic review of randomised trials. Pregnant women diagnosed with gestational diabetes mellitus. Exercise, performed more than once a week, sufficient to achieve an aerobic effect or changes in muscle metabolism. Postprandial blood glucose, fasting blood glucose, glycated haemoglobin, requirement for insulin, adverse events and adherence. This systematic review identified eight randomised, controlled trials involving 588 participants; seven trials (544 participants) had data that were suitable

EvidenceUpdates2016

35. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.

Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. BACKGROUND: Gestational diabetes mellitus (GDM) is any degree of glucose intolerance that first presents and is recognised during pregnancy and usually resolves after the birth of the baby. GDM is associated with increased short- and long-term morbidity for the mother and her baby. Treatment usually includes lifestyle modification and/or pharmacological therapy (oral antidiabetic agents (...) , for the mother and fetus, in treating gestational diabetes. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2016), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (7 April 2016), and reference lists of retrieved studies. SELECTION CRITERIA: All published and unpublished randomised controlled trials or cluster-randomised controlled trials reporting on the use of myo-inositol compared with placebo, no treatment or another

Cochrane2016

36. External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study.

External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. OBJECTIVE: To perform an external validation and direct comparison of published prognostic models for early prediction of the risk of gestational diabetes mellitus, including predictors applicable in the first trimester of pregnancy. DESIGN: External validation of all published prognostic models in large scale, prospective, multicentre cohort study (...) 181 (4.9%) developed gestational diabetes mellitus in pregnancy. 12 prognostic models for the disorder could be validated in the cohort. C statistics ranged from 0.67 to 0.78. Calibration plots showed that eight of the 12 models were well calibrated. The four models with the highest C statistics included almost all of the following predictors: maternal age, maternal body mass index, history of gestational diabetes mellitus, ethnicity, and family history of diabetes. Prognostic models had a similar

BMJ2016

37. Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus

Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus 27538169 2017 12 07 2018 11 13 1539-3704 165 4 2016 08 16 Annals of internal medicine Ann. Intern. Med. Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus. 299-300 10.7326/L16-0106 Gunderson Erica P EP Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy Investigators eng R01 HD050625 HD NICHD NIH HHS United States Journal Article Comment United (...) States Ann Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2015 Dec 15;163(12):889-98 26595611 Ann Intern Med. 2016 Aug 16;165(4):299 27538168 Am J Psychiatry. 2001 Jun;158(6):848-56 11384888 Matern Child Health J. 2009 May;13(3):334-42 18473131 BMC Public Health. 2011 Dec 23;11:952 22196129 Ann Intern Med. 2015 Dec 15;163(12):889-98 26595611 Breast Feeding Diabetes Mellitus, Type 2 Diabetes, Gestational Disease Progression Female Humans Lactation Pregnancy 2016 8 19 6 0 2016 8 19 6 0 2017 12 8 6

Annals of Internal Medicine2016 Full Text: Link to full Text with Trip Pro

38. Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus

Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus 27208340 2016 05 25 2016 12 02 1935-5548 39 6 2016 Jun Diabetes care Diabetes Care Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. 1052-5 10.2337/dc15-2672 To characterize physiologic subtypes of gestational diabetes mellitus (GDM). Insulin sensitivity and secretion were estimated in 809 women at 24-30 weeks' gestation, using oral (...) (57.6 vs. 28.2%, P = 0.003); differences were independent of BMI. Women with predominant insulin secretion defects (30% of GDM) had BMI, fasting glucose, infant birth weights, and risk of adverse outcomes similar to those in women with NGT. Heterogeneity of physiologic processes underlying hyperglycemia exists among women with GDM. GDM with impaired insulin sensitivity confers a greater risk of adverse outcomes. © 2016 by the American Diabetes Association. Readers may use this article as long

EvidenceUpdates2016

39. Different intensities of glycaemic control for women with gestational diabetes mellitus.

Different intensities of glycaemic control for women with gestational diabetes mellitus. BACKGROUND: Gestational diabetes mellitus (GDM) has major short- and long-term implications for both the mother and her baby. GDM is defined as a carbohydrate intolerance resulting in hyperglycaemia or any degree of glucose intolerance with onset or first recognition during pregnancy from 24 weeks' gestation onwards and which resolves following the birth of the baby. Rates for GDM can be as high as 25 (...) RESULTS: We included one Canadian trial of 180 women, recruited between 20 to 32 weeks' gestation, who had been diagnosed with GDM. Data from 171 of the 180 women were published as a conference abstract and no full report has been identified. The overall risk of bias of the single included study was judged to be unclear.The included trial did not report on any of this review's primary outcomes. For the mother, these were hypertension disorders of pregnancy or subsequent development of type 2 diabetes

Cochrane2016

40. Short-term risk of cancer among women with previous gestational diabetes: a population-based study

Short-term risk of cancer among women with previous gestational diabetes: a population-based study 25970380 2016 01 15 2016 10 18 2016 12 30 1464-5491 33 1 2016 Jan Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Short-term risk of cancer among women with previous gestational diabetes: a population-based study. 39-46 10.1111/dme.12796 To evaluate the relationship between gestational diabetes (GDM) and incidence of cancer in women within the first decade postpartum (...) College Research Institute, Women's College Hospital, Toronto, ON, Canada. eng MOP#123263 Canadian Institutes of Health Research Canada Comparative Study Journal Article Research Support, Non-U.S. Gov't 2015 06 15 England Diabet Med 8500858 0742-3071 IM Adult Breast Neoplasms epidemiology etiology Cohort Studies Diabetes, Gestational physiopathology Female Follow-Up Studies Humans Incidence Kaplan-Meier Estimate Middle Aged Ontario epidemiology Postpartum Period Pregnancy Pregnancy in Diabetics

EvidenceUpdates2016